ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SENS Senseonics Holdings Inc

0.3891
0.0041 (1.06%)
Last Updated: 19:18:31
Delayed by 15 minutes
Share Name Share Symbol Market Type
Senseonics Holdings Inc AMEX:SENS AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.0041 1.06% 0.3891 0.3955 0.3829 0.389 1,258,058 19:18:31

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference

06/03/2024 1:05pm

Business Wire


Senseonics (AMEX:SENS)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Senseonics Charts.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Oppenheimer Healthcare MedTech & Services Conference, being held virtually.

Management is scheduled to participate on Wednesday, March 13, 2024, at 12:00pm ET and will hold one-on-one meetings following. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics’ CGM system Eversense® E3 includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.

Senseonics Investor Contact Philip Taylor Gilmartin Group 415-937-5406 Investors@senseonics.com

1 Year Senseonics Chart

1 Year Senseonics Chart

1 Month Senseonics Chart

1 Month Senseonics Chart

Your Recent History

Delayed Upgrade Clock